Grain-sized moxibustion enhances anti-tumor immunity of tumor cell lysate vaccine by inhibiting β-adrenergic signal pathway

Author:

Shen Weiming1,Hu Dan1,Gong Chenyuan1,Fang Cheng1,Luo Jiaojiao1,Wang Lixin1,Yao Chao1,Wu Huangan1,Zhao Chen1,Zhu Shiguo1

Affiliation:

1. Shanghai University of Traditional Chinese Medicine

Abstract

Abstract Tumor vaccines are an attractive immunotherapeutic strategy, but most of their clinical effect are poor. Thus, novel methods to improve antitumor immunity of tumor vaccines is urgently required. We previously found grain-sized moxibustion (gM), an ancient Chinese medicine therapy, could elicit efficient antitumor immune response. This led us to hypothesize that it may benefit tumor vaccines. In this study, we found that gM and TL vaccine synergistically inhibited the Lewis lung cancer (LLC) tumor growth, and this effect was abolished completely by CD4+ T cell depletion, partly by NK cell depletion, but not by CD8+ T cell depletion. Mechanically, gM and TL vaccine synergistically promoted DCs activation in tumor adjacent lymph node. Data of RNA-sequence showed gM could inhibit β-adrenergic signal pathway and the β-blocker propranolol elicited similar effect for TL vaccine to increase tumor regression and DCs activation. These results implied that gM enhanced TL vaccine by inhibiting β-adrenergic receptor and might be a good adjuvant for tumor vaccines.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Morse MA, Gwin WR 3rd, Mitchell DA. Vaccine Ther Cancer: Then Now Target Oncol. 2021;16:121–52.

2. Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses;Vermaelen K;Front Immunol,2019

3. History of acupuncture research;Zhuang Y;Int Rev Neurobiol,2013

4. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer;Hu D;J Cell Mol Med,2021

5. CD4(+) T cells in cancer;Speiser DE;Nat Cancer,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3